Newly launched — under active development.
BidragskollenBidragskollen
Back to Innovation & R&D

Call from Swelife and Medtech4Health to BioReperia

3 million SEK in grants for projects within functional personalised diagnostics of bladder cancer.

Amount

3 million

Funding rate

Varies — depends on the scope of the project and the grant provider's assessment.

Deadline

No fixed deadline specified — applications are usually accepted continuously. Check current dates with the grant provider.

About the grant

BioReperia recently received 3 million in a call from Swelife and Medtech4Health for their project on functional personalised diagnostics of bladder cancer. The funds will be used, among other things, to start a clinical study and to develop a commercialisation plan for the product. The project aims to develop the ZTX® test for personalised treatment of patients with bladder cancer, scale up data from proof-of-concept, initiate a clinical study to predict patients' treatment responses, and develop and automate production. The grant is a collaboration between BioReperia, Region Östergötland, Umeå University and Norrbotten University Hospital.

Requirements

The grant provider does not list any fixed requirements in advance for this support. In practice, an individual assessment of your application is made — who you are, what the project is about and how well it fits the purpose of the grant. Read the source below for the applicable conditions before applying.

What types of project are suitable?

Source

Read more at LEAD

Frequently asked questions about Call from Swelife and Medtech4Health to BioReperia

Quick answers to what people ask most about this grant.

Apply with AI

Let our AI create an application draft based on your company and project.

Apply with AI

Find more grants

Not the right grant for you? Explore similar ones

Other grants in the category Innovation & R&D that might suit you.

Let our AI find your grant